SHERRI VAN EVEREN, PharmD has been in Ophthalmology research for over 10 years and was instrumental in helping initiate the Jack McGovern Coats’ Disease collaboration with Genentech. Currently, she is the Vice President of Clinical Development, Ophthalmology for REGENXBIO developing gene therapies for patients with unmet needs. In addition to participating on the Board, Sherri will be leading our Foundation’s scientific initiatives, including setting up a patient registry and supporting additional research collaborations in Coats’ Disease.